Prot# OOC-ACM-302: A Phase 3, Randomized, Open-Label, Active Controlled, Multicenter Study to Evaluate Maintenance of Response, Safety and Patient Reported Outcomes in Acromegaly Patients Treated with Octreotide Capsules, and in Patients Treated with Stan

Project: Research project

Project Details

Effective start/end date3/18/161/24/22


  • Pharm-Olam International Ltd. (Prot# OOC-ACM-302 // Prot# OOC-ACM-302)
  • Chiasma, Inc. (Prot# OOC-ACM-302 // Prot# OOC-ACM-302)